# Embracing quantitative signal detection methods as a smaller MAH

- Articles, Resources  
- June 25, 2026

Qinecsa Chief Operating Officer, John Cogan, has been featured in Journal of Clinical Studies latest issue, where he shares insights on priorities for quantitative signal detection methods as a smaller MAH.

[Read article](https://issuu.com/senglobal1/docs/2025-jcs-winter_acf5e27952fbc5?fr=xKAE9_zMzMw)

## Recent Articles

### [The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?](/content/resources/the-productivity-crisis-that-persists-even-now-what-will-it-take-to-free-up-pv-professionals-to-assess-safety-rather-than-coordinate-data/index.html)

- July 28, 2026

### [Real-Time Safety Signals Drive Continuous PV Insight](/content/articles/real-time-safety-signals-drive-continuous-pv-insight/index.html)

- May 27, 2026

### [From Complaint Handling to Active Surveillance](/content/resources/from-complaint-handling-to-active-surveillance/index.html)

- May 5, 2026

### [Continuous Safety Surveillance for Medical Devices](/content/resources/continuous-safety-surveillance-for-medical-devices/index.html)

- May 5, 2026

### [Are patient outcomes getting lost in safety data complexity?](/content/resources/are-patient-outcomes-getting-lost-in-safety-data-complexity/index.html)

- May 5, 2026

### [From data collection to interrogation: why 2026 is the inflection point for combination product safety surveillance](/content/resources/from-data-collection-to-interrogation-why-2026-is-the-inflection-point-for-combination-product-safety-surveillance/index.html)

- April 30, 2026

[PreviousDeveloping a Robust Drug Safety Framework for Clinical Development](/content/case-studies/developing-a-robust-drug-safety-framework-for-clinical-development/index.html)

[NextWhen the Master File Falls Behind: The Problem of PSMF Latency](/content/resources/when-the-master-file-falls-behind-the-problem-of-psmf-latency/index.html)